Related Experiment Video
Updated: Jun 18, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Pediatric Perspectives on Liver Cirrhosis: Unravelling Clinical Patterns and Therapeutic Challenges
Lorenza Forna1,2, Laura Bozomitu1,2, Vasile Valeriu Lupu1,2
1Pediatrics-"Sf. Maria" Clinical Emergency Children's Hospital, 700309 Iași, Romania.
Insights
Pediatric liver cirrhosis, caused by chronic cholestasis, metabolic disorders, and hepatitis, requires early diagnosis and comprehensive management. Advances in vaccination and transplantation have improved outcomes for children with this condition.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Internal Medicine
Background:
- Liver cirrhosis in children poses unique challenges due to diverse causes like chronic cholestasis, metabolic disorders, and hepatitis.
- Limited therapeutic options and complex clinical presentations complicate pediatric cirrhosis management.
Purpose of the Study:
- To review the etiology, clinical features, diagnostics, and management of pediatric liver cirrhosis.
- To synthesize current literature on complications and liver transplantation in pediatric cirrhosis.
Main Methods:
- A narrative review of existing literature.
- Synthesis of data on etiology, clinical presentation, diagnosis, and treatment.
Main Results:
- Pediatric liver cirrhosis epidemiology is changing, with decreased rates due to vaccination and viral hepatitis management.
- Liver transplantation programs have enhanced the management of cirrhosis complications in children.
Conclusions:
- Early diagnosis and multidisciplinary management are key to improving outcomes for pediatric liver cirrhosis.
- Age-appropriate care and advanced treatment strategies are vital for affected children.
Abstract:
Background: Liver cirrhosis presents significant challenges in the pediatric population due to a complex interplay of etiological factors, clinical manifestations, and limited therapeutic options. The leading contributors to cirrhosis among pediatric patients are chronic cholestasis, metabolic disorders present from birth, and long-term hepatitis. Materials and method: Our narrative review aimed to synthesize literature data on the etiology, clinical picture, diagnostic techniques, optimal management of complications, and timely transplantation. Results: The epidemiology of liver cirrhosis in pediatric patients is evolving. The introduction of a universal vaccination and effective long-term viral suppression in viral hepatitis have significantly decreased complications rates. Liver transplantation programs worldwide have also improved the management of cirrhosis complications. Conclusions: Early diagnosis, comprehensive management strategies, and advancements in treatment modalities are critical for improving outcomes. Understanding these differences is crucial in providing age-appropriate care and support for those affected by cirrhosis.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Factors Affecting Drug Response: Overview

